Ono Pharmaceutical Co., Ltd. (TYO:4528)

Ono Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	160,982	166,141	96,135	69,112	61,045	69,005
Short-Term Investments	9,858	-	20	60	2,978	614
Cash & Short-Term Investments	170,840	166,141	96,155	69,172	64,023	69,619
Cash Growth	67.05%	72.78%	39.01%	8.04%	-8.04%	14.75%
Receivables	152,211	136,066	114,396	99,788	84,269	76,834
Inventory	77,621	48,629	44,814	41,817	39,151	32,906
Prepaid Expenses	-	14,699	10,465	10,952	10,003	8,094
Other Current Assets	31,254	48,061	79,271	59,537	50,196	37,769
Total Current Assets	431,926	413,596	345,101	281,266	247,642	225,222
Property, Plant & Equipment	106,733	104,752	108,420	112,131	113,866	114,628
Long-Term Investments	110,937	297,170	324,178	255,997	281,393	232,344
Other Intangible Assets	354,792	57,288	69,134	64,734	70,322	66,436
Long-Term Deferred Tax Assets	43,011	40,863	35,604	25,074	33,619	34,817
Other Long-Term Assets	12,492	-1	-	1	-	-3
Total Assets	1,082,304	913,668	882,437	739,203	746,842	673,444
Accounts Payable	61,124	60,691	66,794	49,689	39,163	34,439
Accrued Expenses	-	13,493	11,726	10,824	10,393	10,425
Short-Term Debt	30,000	-	-	-	-	-
Current Portion of Leases	3,005	2,310	2,490	2,301	2,023	2,188
Current Income Taxes Payable	2,220	24,518	40,896	2,284	20,804	22,975
Other Current Liabilities	25,489	2,612	1,023	828	21,350	21,302
Total Current Liabilities	121,838	103,624	122,929	65,926	93,733	91,329
Long-Term Debt	112,500	-	-	-	-	-
Long-Term Leases	8,781	6,552	6,678	6,501	7,030	6,173
Long-Term Deferred Tax Liabilities	13,812	1,013	983	1,009	1,052	1,059
Other Long-Term Liabilities	572	580	684	771	814	813
Total Liabilities	260,809	115,063	134,624	77,529	105,685	105,422
Common Stock	17,358	17,358	17,358	17,358	17,358	17,358
Additional Paid-In Capital	-	17,458	17,080	17,241	17,231	17,229
Retained Earnings	791,609	768,183	709,890	644,754	583,363	524,605
Treasury Stock	-63,096	-63,233	-54,161	-74,683	-44,705	-44,737
Comprehensive Income & Other	70,047	53,195	51,702	51,236	62,300	48,029
Total Common Equity	815,918	792,961	741,869	655,906	635,547	562,484
Minority Interest	5,577	5,644	5,944	5,768	5,610	5,538
Shareholders' Equity	821,495	798,605	747,813	661,674	641,157	568,022
Total Liabilities & Equity	1,082,304	913,668	882,437	739,203	746,842	673,444
Total Debt	154,286	8,862	9,168	8,802	9,053	8,361
Net Cash (Debt)	16,554	157,279	86,987	60,370	54,970	61,258
Net Cash Growth	-82.33%	80.81%	44.09%	9.82%	-10.26%	4.77%
Net Cash Per Share	35.24	327.64	178.12	121.58	110.12	121.53
Filing Date Shares Outstanding	469.71	469.65	488.33	488.31	499.21	499.12
Total Common Shares Outstanding	469.71	469.65	488.33	488.24	499.14	499.12
Working Capital	310,088	309,972	222,172	215,340	153,909	133,893
Book Value Per Share	1737.08	1688.42	1519.18	1343.40	1273.28	1126.95
Tangible Book Value	438,713	735,673	672,735	591,172	565,225	496,048
Tangible Book Value Per Share	934.01	1566.44	1377.61	1210.81	1132.39	993.85

Source: S&P Capital IQ. Standard template. Financial Sources.